Phase 3

Efficacy of SENS-401 in Subjects With Severe or Profound Sudden Sensorineural Hearing Loss

November 2, 2020

https://clinicaltrials.gov/ct2/show/NCT03603314?type=Intr&cond=Hearing+Loss&lupd_s=05%2F05%2F2020&lupd_d=14&sort=nwst

Condition : Severe Sudden Sensorineural Hearing Loss

Interventions : Drug: SENS-401; Other: Placebo Oral Tablet

Sponsor : Sensorion

Recruiting

Efficacy of SENS 401 in Subjects With Severe or Profound Sudden Sensorineural Hearing Loss

NCT03603314

Fri, 27 Jul 2018 12:00:00 EDT

Last Update Posted: 05/19/20 06:40AM

August 7, 2020

https://clinicaltrials.gov/ct2/show/NCT02809118?type=Intr&cond=Hearing+Loss&lupd_s=07%2F24%2F2020&lupd_d=14&sort=nwst

Condition : Hearing Loss, Idiopathic Sudden Sensorineural

Interventions : Drug: AM-111 0.4 mg/ml; Drug: AM-111 0.8 mg/ml; Other: Placebo

Sponsor : Auris Medical, Inc.

Terminated

Efficacy and Safety of AM-111 as Acute Sudden Sensorineural Hearing Loss Treatment

NCT02809118

Wed, 22 Jun 2016 12:00:00 EDT

Last Update Posted: 08/07/20 06:52AM

March 25, 2020

https://clinicaltrials.gov/ct2/show/NCT03331627?type=Intr&cond=Hearing+Loss&lupd_s=03%2F27%2F2019&lupd_d=14&sort=nwst

Condition : Acute Hearing Loss

Intervention : Drug: STR001-IT and STR001-ER

Sponsor : Strekin AG

Recruiting

Safety and Efficacy of STR001-IT and STR001-ER in Patients With SSHL

NCT03331627

Mon, 06 Nov 2017 12:00:00 EST

Last Update Posted: 04/10/19 08:35AM

April 29, 2019

https://clinicaltrials.gov/ct2/show/NCT02903355?type=Intr&cond=Hearing+Loss&lupd_s=04%2F15%2F2019&lupd_d=14&sort=nwst

Condition : Noise-induced Hearing Loss

Interventions : Drug: D-methionine; Drug: Placebo

Sponsor : Southern Illinois University

Terminated

Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)

NCT02903355

Fri, 16 Sep 2016 12:00:00 EDT

Last Update Posted: 04/29/19 08:25AM